Allergy Therapeutics PLC AGYTF:OTCPK

RT Quote | Exchange | USD
Last | 11:10 AM EST
0.159UNCH (UNCH)
Volume
300
52 week range
0.08 - 0.35
Loading...
  • Open0.159
  • Day High0.159
  • Day Low0.159
  • Prev Close0.159
  • 52 Week High0.35
  • 52 Week High Date03/18/22
  • 52 Week Low0.08
  • 52 Week Low Date12/29/22

Key Stats

  • Market Cap49.6M
  • Shares Out653.95M
  • 10 Day Average Volume300
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change106.49

KEY STATS

  • Open0.159
  • Day High0.159
  • Day Low0.159
  • Prev Close0.159
  • 52 Week High0.35
  • 52 Week High Date03/18/22
  • 52 Week Low0.08
  • 52 Week Low Date12/29/22
  • Market Cap49.6M
  • Shares Out653.95M
  • 10 Day Average Volume300
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change106.49

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-6.12
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Allergy Therapeutics PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Allergy Therapeutics plc is a United Kingdom-based biotechnology company. The Company is focused on the treatment and diagnosis of allergic disorders, including aluminum-free immunotherapy vaccines that have the potential to cure disease. The Company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries. Its pipeline of products in clinical development includes vaccines...
Peter Jensen
Independent Non-Executive Chairman of the Board
Manuel Llobet
Chief Executive Officer, Executive Director
Martin Hopcroft
Interim Chief Financial Officer
Address
Dominion Way
Worthing
BN14 8SA
United Kingdom